World Health Organization

Executive Board reviews WHO report on follow-up to the UN High-Level Meeting on TB

The World Health Organization (WHO) Executive Board reviewed a report of the WHO Director-General on the follow-up to the UN High-Level Meeting on TB held in September 2018.

Read More →

Civil society, countries and partners commit to step up action to end TB in the Western Pacific Region

25 January 2018 | Seoul, Republic of Korea – An outcome statement to step up action to end TB was released today outlining pledges of support from civil society, countries and partners. The statement highlights key opportunities, actions and next steps to empower and strengthen community and civil society engagement to end TB, and is the culmination of a landmark consultation organized by the WHO Regional Office of the Western Pacific and the Korean Institute of Tuberculosis (KIT) on 11-13 December. The workshop brought together more than 40 participants from countries and partners, including the regional members of the revamped WHO Civil Society Task Force to strengthen global and regional mechanisms for civil society engagement.

Read More →

New project launched to consolidate sustainable TB care models in eastern Europe and central Asia

A new Tuberculosis Regional Eastern European and Central Asian Project, referred to as TB-REP 2.0, has been launched. This project for 2019 to 2022, building on the previous TB-REP from 2016 to 2018, will consolidate past achievements and address new and remaining challenges while ensuring continuity. In particular, it will focus on improving tuberculosis (TB) prevention and care outcomes.

Read More →

European Laboratory Initiative on TB expands to cover HIV and viral hepatitis

To strengthen and streamline the joint response to tuberculosis (TB), HIV and viral hepatitis in the WHO European Region, the WHO-established European Laboratory Initiative on TB extended its scope to HIV and viral hepatitis. Through this development, WHO aims to address more effectively the specific needs of the Region.

Read More →

WHO updates its treatment guidelines for MDR/RR-TB

The updated WHO treatment guidelines recommend that drug-resistant TB be treated with oral drugs only, including newer, more potent drugs with fewer side effects.

Read More →

WHO Global TB Program: 2018 year in review

The World Health Organization (WHO) Global TB Program released a newsletter highlighting the overall progress in the global TB response in 2018.

Read More →

Revamped WHO Civil Society Task Force

The World Health Organization has revamped its Civil Society Task Force on TB to strengthen collaboration for accelerating progress towards ending TB.

Read More →

First Anniversary of the 1st WHO Global Ministerial Conference on Ending TB

The past twelve months have seen unparalleled attention to the global TB response. In less than a year, the fight to end TB has been in the spotlight twice with two high-level meetings: the first WHO Global Ministerial Conference on Ending TB held in Moscow in November 2017 and the first-ever United Nations High-Level Meeting on the fight to end TB held in New York in September 2018.

Read More →

WHO strongly supports global sharing of data from TB clinical trials to maximize learning and accelerate discoveries

06 November 2018 | Geneva: To advance the development of new treatments against all forms of TB and maximize the impact of studies and trials undertaken in this area, WHO and partners have initiated a series of pioneering initiatives over the past few years. These are now bearing fruit.

Read More →

WHO at the Union World Conference on Lung Health

The 49th Union World Conference on Lung Health, held from 24-27 October in The Hague brought together an unprecedented number of stakeholders from the TB community and beyond. The World Health Organization (WHO) organized several meetings and consultations on the side-lines of the conference.

Read More →

Page 1 of 16 · Total posts: 10

1 2 Last→